Literature DB >> 30540086

CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS.

Letícia Baltieri1, Elinton Adami Chaim1, Felipe David Mendonça Chaim1, Murillo Pimentel Utrini1, Martinho Antonio Gestic1, Everton Cazzo1.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the commonest hepatopathy worldwide.
OBJECTIVE: To investigate the correlations between NAFLD histopathological features and the levels of adipokines (adiponectin, leptin, and resistin) and circulating inflammatory markers (interleukin-6 [IL-6], interleukin-8 [IL-8], tumor necrosis factor alpha [TNF-α], and C-reactive protein [CRP]).
METHODS: This is an exploratory cross-sectional study, which enrolled 19 women with obesity who underwent bariatric surgery. Biochemical characteristics evaluated included the levels of adiponectin, leptin, resistin, IL-6, IL-8, TNF-α, and CRP. NAFLD was assessed through histological examination of liver biopsies carried out during the surgical procedures.
RESULTS: The mean age of the study group was 37.3±8.2 years old; mean BMI was 36.2±2.5 kg/m2. Among individuals with liver fibrosis, the levels of IL-8 were significantly higher (24.4 ± 9.7 versus 12.7 ± 6.6; P=0.016726). The intensity of fibrosis presented a significant negative correlation with the levels of adiponectin (R= -0.49379; P=0.03166); i.e. the higher the levels of adiponectin, the lower the intensity of fibrosis. The intensity of steatohepatitis presented a significant negative correlation with the levels of adiponectin (R= -0.562321; P=0.01221); this means that the higher the levels of adiponectin, the lower the intensity of steatohepatitis.
CONCLUSION: Adiponectin levels were inversely correlated with the severity of fibrosis and steatohepatitis, whereas IL-8 levels were higher in individuals with liver fibrosis among individuals with obesity and NAFLD undergoing bariatric surgery. The use of these markers to assess NAFLD may bring significant information within similar populations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30540086     DOI: 10.1590/S0004-2803.201800000-62

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  5 in total

1.  Roux-en-Y Gastric Bypass as a Treatment for Hepatic Iron Overload: An Exploratory Study.

Authors:  Rafael Nascimento de Jesus; Guilherme Hoverter Callejas; Felipe David Mendonça Chaim; Martinho Antonio Gestic; Murillo Pimentel Utrini; Francisco Callejas-Neto; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2022-05-11       Impact factor: 3.479

2.  Evaluation of the Mechanism of Jiedu Huazhuo Quyu Formula in Treating Wilson's Disease-Associated Liver Fibrosis by Network Pharmacology Analysis and Molecular Dynamics Simulation.

Authors:  Shao-Peng Huang; Sen Chen; Yan-Zhen Ma; An Zhou; Hui Jiang; Peng Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-06       Impact factor: 2.650

3.  High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease.

Authors:  Cuiling Zhu; Dongdong Huang; Huihui Ma; Chunhua Qian; Hui You; Le Bu; Shen Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-06       Impact factor: 6.055

Review 4.  Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future.

Authors:  João Paulo Margiotti Dos Santos; Mariana Canevari de Maio; Monike Alves Lemes; Lucas Fornari Laurindo; Jesselina Francisco Dos Santos Haber; Marcelo Dib Bechara; Pedro Sidnei do Prado; Eduardo Costa Rauen; Fernando Costa; Barbara Cristina de Abreu Pereira; Uri Adrian Prync Flato; Ricardo de Alvares Goulart; Eduardo Federighi Baisi Chagas; Sandra Maria Barbalho
Journal:  Int J Mol Sci       Date:  2022-01-02       Impact factor: 5.923

Review 5.  Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?

Authors:  Vera Francisco; Maria Jesus Sanz; José T Real; Patrice Marques; Maurizio Capuozzo; Djedjiga Ait Eldjoudi; Oreste Gualillo
Journal:  Biology (Basel)       Date:  2022-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.